Title : Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity.

Pub. Date : 2012 Jul

PMID : 22565589






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Prospective comparison of three enoxaparin dosing regimens to achieve target anti-factor Xa levels in hospitalized, medically ill patients with extreme obesity. Enoxaparin coagulation factor X Homo sapiens
2 We prospectively compared three enoxaparin dosing regimens for the achievement of goal peak anti-Factor Xa levels in medically ill patients (n 5 31) with extreme obesity (body mass index (BMI) 40 kg/m2). Enoxaparin coagulation factor X Homo sapiens
3 To our knowledge this is the first prospective comparative study demonstrating that in extremely obese, medically ill patients enoxaparin 0.5 mg/kg QDay is superior to FD and LD enoxaparin for the achievement of target anti-Factor Xa levels. Enoxaparin coagulation factor X Homo sapiens